Vorinostat: Revision history

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

16 December 2023

  • curprev 11:1211:12, 16 December 2023‎ Ai talk contribs‎ 2,822 bytes +2,822‎ Created page with "== Introduction == Vorinostat, also known as SAHA (suberoylanilide hydroxamic acid), is a histone deacetylase inhibitor (HDAC inhibitor) that has been approved by the FDA for the treatment of cutaneous T-cell lymphoma (CTCL). This drug works by interfering with the function of histone deacetylase, an enzyme that plays a crucial role in the regulation of gene expression. Image:Detail-55..."
Retrieved from "https://canonica.ai/page/Vorinostat"